Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies

Journal of Hypertension

Volumn 14, Issue 12, 1996, Pages 1403-1408

  Sasaki, Miwa ^a   Oki, Takashi ^a   Iuchi, Arata ^a   Tabata, Tomotsugu ^a   Yamada, Hirotsugu ^a   Manabe, Kazuyo ^a   Fukuda, Kazuyo ^a   Abe, Miho ^a   Ito, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Angiotensin converting enzyme genotype; Enalapril; Hypertension; Left ventricular diastolic filling; Left ventricular hypertrophy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; DOPPLER ECHOCARDIOGRAPHY; ENZYME BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; GENOTYPE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030474233     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199612000-00003     Document Type: Article

References (31)

1. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991, 83:1849-1865.
2. Villareal FJ, Kim NN, Ungab GD, Printz MP, Dillamann WH: Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993, 88:2849-2861.
3. Zhao Y, Higashimori K, Higata J: Significance of deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 1994, 17:55-57.
4. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, et al.: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Med Sci 1994, 91: 3662-3665.
5. Cambien F, Poirier O, Lecerf L, Evans A, Cambus JP, Arveiler D, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359: 641-644.
6. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994, 90:2622-2628.
7. Raynords MVR, Bristow MR, Abraham WT, Lowes BD, Zisman LS, et al.: Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993, 342:1073-1075.
8. Marian AJ, Yu Q, Workman R, Greve G, Roberts R: Angiotensin-converting enzyme polymorphisms in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993, 342:1085-1086.
9. Ohishi M, Fujii K, Minamino T: A potent genetic risk factor for restenosis. Nature Genet 1993, 5:324-325.
10. Castellano M, Muiesan ML, Rizzoni D, Beschi M, Pasini G, Cinelli A, et al.: Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. Circulation 1994, 91:2721-2724.
11. Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakotovao R, Gonzales MF, et al.: Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am J Hum Genet 1988, 43:774-780.
12. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin II-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
13. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin II-converting enzyme in human circulating mononuclear cell: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993, 290: 33-40.
14. Oki T, Fukuda N, Iuchi A, Tabata T, Kiyoshige K, Fujimoto T, et al.: Changes in left ventricular inflow velocities during preload alteration in hypertrophic cardiomyopathy. Am J Cardiol 1996, 77:430-435.
15. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase 1). Nucleic Acid Res 1992, 20:1433.
16. Kasahara Y, Ashihara Y: Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 1981, 27:1922-1925.
17. Teichholz LE, Kreulen T, Herman MM Gorlin R: Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976, 37:7-11.
18. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613-618.
19. Myreng N, Smiseth OA: Assessment of left ventricular relaxation by Doppler echocardiography. Circulation 1990, 81:260-266.
20. Oki T, Fukuda N, Iuchi A, Tabata T, Kiyoshige K, Manabe K, et al.: Evaluation of left ventricular diastolic hemodynamics from the left ventricular inflow and pulmonary venous flow velocities in hypertrophic cardiomyopathy. Jpn Heart J 1995, 36:617-627.
21. Kojima S, Inenaga T, Matsuoka H, Kuramochi M, Omae T, Nara N, et al.: The association between salt sensitivity of blood pressure and some factors with polymorphism [abstract]. J Hypertens 1994, 12 (suppl 3): 167.
22. Morise T, Takeuchi N, Takeda R: Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet 1994, 343:125.
23. Zee RYL, Lou N, Griggiths LR, Morris BJ: Association analysis of a polymorphism of the angiotensin II-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992, 184: 9-15.
24. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al.: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 330:1634-1638.
25. Harrap SB, Davidson HR, Connor JM, Soubner F, Corvol P, Fraser R, et al.: The angiotensin II converting enzyme gene and predisposition to high blood pressure. Hypertension 1993, 21:455-460.
26. Schmidt S, van Hooft IMS, Grobbee DE, Ganten D, Ritz E: Polymorphism of the angiotensin II converting enzyme gene is apparently not related to high blood pressure: Dutch hypertension and offspring study. J Hypertens 1993, 11:345-348.
27. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, et al.: Association analysis of a polymorphism of the angiotensin II-converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993, 191:399-404.
28. Shiota N, Miyazaki M, Okunishi H: Increase of angiotensin converting enzyme gene expression in the hypertensive aorta. Hypertension 1992, 20:168-174.
29. Pearlman ES, Weber KT, Janicki JS, Pietra GG, Fishman AP: Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest 1982, 46:158-164.
30. Oki T, Fukuda N, Iuchi A, Tabata T, Sasaki M, Kawahara K, et al.: Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension. J Cardiac Failure 1995, 1:365-370.
31. Dzau VJ: Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993, 153:937-942.